Jon Matsumura: Abbott PROTECT

"As a member of the PROTECT multispecialty Executive Committee, I have been impressed with the continuing downward trend in stroke rates with protected carotid stenting for patients at high risk for carotid endarterectomy from the earliest clinical trials with first-generation devices 10 years ago.”

“These results are related to several factors, including process of care improvements that skilled physicians are developing, and to the continuing improvements in device technology.”

“Abbott's PROTECT study represents state-of-the-art skills and technology for carotid artery stenting.”

Jon Matsumura, MD
Professor of Surgery
University of Wisconsin School of Medicine and Public Health